No Detail Found!

Comparison of mean time of achieving full enteral feed with oral erythromycin as compared to placebo for the treatment of gastrointestinal dysmotility in low-birth- weight preterm neonates

Author(s)
ARIF ZAHEER Continental Medical College, Lahore,Pakistan
FARYAD HUSSAIN Fatima Jinnah Medical University, Lahore,Pakistan
MADIHA ALI Children Hospital Lahore,Pakistan
NOSHEEN FATIMA Quaid-e-Azam Medical College,Pakistan
AMIR RASHID Postgraduate Medical Institute/ Ameer-ud-Din Medical College/Lahore General Hospital, Lahore,Pakistan
AGHA SHABBIR ALI Akhtar Saeed Medical College.Pakistan
Abstract
Objective: To compare the mean time to receive a full feed with oral erythromycin compared with placebo for the treatment of intestinal dysmotility among low birth weight preterm neonates. Methods: It was randomized controlled trial & 100 preterm neonates were randomly allocated to two groups using lottery method. Group A received erythromycin (12.5mg/kg/dose every 6 hour through oral route or nasogastric tube) while Group B received placebo solution (equivalent volume of normal saline orally 6 hourly). Both groups received erythromycin and placebo for 14 days. If patient developed necrotizing enterocolitis or deteriorated after start of study, erythromycin and placebo solution was discontinued. Results: The mean age of all cases was 6.74 ± 2.29 days while mean age in Erythromycin group was 6.66 ± 2.48 days and in placebo group was 6.82 ± 2.10 days. In erythromycin group there were 35(70%) male and 15(30%) female cases while in placebo group there 21(42%) male and 29(58%) female cases. In erythromycin group 19(38%) cases were on mother feeding and 31(62%) cases were formula feeding and in placebo group 23(46%) cases were on mother feeding while 27(54%) cases were on formula feeding. The mean time to achieve enteral feeding in erythromycin group was 23.04 ± 4.42 days and in placebo was 26.46 ± 4.95 days. The mean time to achieve enteral feeding was statistically less in erythromycin group was statistically less as compared to placebo group, p-value < 0.001. Conclusion: The mean time of achieving full enteral feed with oral erythromycin was significantly less as compared to placebo for treatment of gastrointestinal dysmotility in low-birth-weight preterm neonates. So, therapeutic effects of erythromycin can be utilized to achieve early feeding. This can also help to minimize the related morbidity and hospital stay.
Publication Details
Page(s) 78-83
Published Journal: Pakistan Postgraduate Medical Journal, Volume: 32, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
Prematurity, low birth weight, Preterm birth, oral erythromycin, Gastrointestinal dysmotility, Enteral feeding
0

Citations

0

Downloads

111

Views